ST Elevation Myocardial Infarction
134
28
34
37
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.7%
5 terminated out of 134 trials
88.1%
+1.6% vs benchmark
25%
34 trials in Phase 3/4
16%
6 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (134)
STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial
CArdiac Brief INtervention: A Feasibility Study to Promote Engagement With Cardiac Rehabilitation
Early Discharge Pathway Registry
Dapagliflozin in STEMI
STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
Cell Free DNA in Cardiac Sarcoidosis
Rivaroxaban for Slow Coronary Flow After PCI in STEMI
Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease
A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI
Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI
Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution
The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial
Evolocumab in STEMI
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
CRP Apheresis in STEMI